TURNER CHRISTOPHER DURANT

PrivateCIK: 1862146
Location

CAMBRIDGE, MA

TURNER CHRISTOPHER DURANT (Chief Medical Officer) sold 11.9% of their position (7.42K shares) of NUVALENT, INC. on the open market

Open‑market sale worth $721.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 7 sales
InsiderTURNER CHRISTOPHER DURANTCIK 1862146
IssuerNUVALENT, INC.CIK 1861560
Officer· Chief Medical Officer
Since Jul 2021
+27.58K
Net shares
Net buyer
$721.3K
Total sold
7
Open market trades
0B · 7S
9
Total transactions
35K acquired · 7.42K disposed
Non-Derivative Transactions8

Class A Common Stock

Direct
S · Sale

Shares

871.00

Price / share

$96.06

Trade value

$83.67K

% of position

1.4%
1/5/2026
62.55K61.68K

Class A Common Stock

Direct
S · Sale

Shares

1.12K

Price / share

$96.85

Trade value

$108.38K

% of position

1.8%
1/5/2026
61.68K60.56K

Class A Common Stock

Direct
S · Sale

Shares

1.93K

Price / share

$97.96

Trade value

$188.96K

% of position

3.2%
1/5/2026
60.56K58.63K

Class A Common Stock

Direct
S · Sale

Shares

317.00

Price / share

$98.52

Trade value

$31.23K

% of position

0.5%
1/5/2026
58.63K58.31K

Class A Common Stock

Direct
S · Sale

Shares

1.32K

Price / share

$96.75

Trade value

$127.81K

% of position

2.3%
1/6/2026
58.31K56.99K

Class A Common Stock

Direct
S · Sale

Shares

1.64K

Price / share

$97.33

Trade value

$159.13K

% of position

2.9%
1/6/2026
56.99K55.35K

Class A Common Stock

Direct
S · Sale

Shares

225.00

Price / share

$98.40

Trade value

$22.14K

% of position

0.4%
1/6/2026
55.35K55.13K

Class A Common Stock

Direct
A · Award

Shares

+17.50K

Price / share

Trade value

% of position

31.7%
1/7/2026
55.13K72.63K
Total

Net shares

+10.08K

Net value

-$721.32K

Derivative Transactions1

Stock Option (Right to Buy)

Direct
A · Award
Converts to

Class A Common Stock

17.50K shares

Shares

+17.50K

Strike price

106.82

Held after

17.50K

Exercisable

1/7/2026
TURNER CHRISTOPHER DURANT — Insider Transaction (Form 4) Filed Jan 7, 2026 | Finecho